IL18 and peeling skin syndrome: Subgroup analysis subsequently showed increased IL-18 in serum of pSS patient (SMD = 1.28, 95% CI 0.68–1.88, P < .001), with significant heterogeneity (I2 = 91%, P < .001) (Fig. 3).